AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - BIT:1AMGN - US0311621009 - Common Stock
253.8 EUR
-2.75 (-1.07%)
1AMGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 76 industry peers in the Biotechnology industry. While 1AMGN belongs to the best of the industry regarding profitability, there are concerns on its financial health. 1AMGN may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
1AMGN had positive earnings in the past year.
In the past year 1AMGN had a positive cash flow from operations.
In the past 5 years 1AMGN has always been profitable.
In the past 5 years 1AMGN always reported a positive cash flow from operatings.
1.2 Ratios
1AMGN has a Return On Assets of 7.53%. This is amongst the best in the industry. 1AMGN outperforms 85.33% of its industry peers.
The Return On Equity of 1AMGN (89.11%) is better than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.12%, 1AMGN belongs to the top of the industry, outperforming 90.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1AMGN is in line with the industry average of 12.82%.
The last Return On Invested Capital (14.12%) for 1AMGN is above the 3 year average (13.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROIC | 14.12% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
The Profit Margin of 1AMGN (18.96%) is better than 86.67% of its industry peers.
In the last couple of years the Profit Margin of 1AMGN has declined.
Looking at the Operating Margin, with a value of 31.30%, 1AMGN belongs to the top of the industry, outperforming 90.67% of the companies in the same industry.
In the last couple of years the Operating Margin of 1AMGN has declined.
With a decent Gross Margin value of 69.71%, 1AMGN is doing good in the industry, outperforming 65.33% of the companies in the same industry.
1AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1AMGN is still creating some value.
Compared to 1 year ago, 1AMGN has more shares outstanding
1AMGN has less shares outstanding than it did 5 years ago.
1AMGN has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of 1AMGN is 4.94, which is a neutral value as it means it would take 1AMGN, 4.94 years of fcf income to pay off all of its debts.
1AMGN has a better Debt to FCF ratio (4.94) than 81.33% of its industry peers.
A Debt/Equity ratio of 7.24 is on the high side and indicates that 1AMGN has dependencies on debt financing.
The Debt to Equity ratio of 1AMGN (7.24) is worse than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Altman-Z | N/A |
ROIC/WACC1.5
WACC9.43%
2.3 Liquidity
1AMGN has a Current Ratio of 1.31. This is a normal value and indicates that 1AMGN is financially healthy and should not expect problems in meeting its short term obligations.
1AMGN's Current ratio of 1.31 is on the low side compared to the rest of the industry. 1AMGN is outperformed by 66.67% of its industry peers.
A Quick Ratio of 0.98 indicates that 1AMGN may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, 1AMGN is not doing good in the industry: 69.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.26%, which is quite good.
1AMGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.97% yearly.
The Revenue has grown by 12.88% in the past year. This is quite good.
1AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.43% yearly.
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
3.2 Future
Based on estimates for the next years, 1AMGN will show a small growth in Earnings Per Share. The EPS will grow by 4.13% on average per year.
1AMGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.12% yearly.
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.46, 1AMGN is valued correctly.
Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 89.33% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.83, 1AMGN is valued a bit cheaper.
1AMGN is valuated correctly with a Price/Forward Earnings ratio of 13.32.
Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
1AMGN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 32.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 13.32 |
4.2 Price Multiples
1AMGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 82.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaply inside the industry as 90.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.88 | ||
| EV/EBITDA | 12.48 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.59
PEG (5Y)2.25
EPS Next 2Y5.44%
EPS Next 3Y4.87%
5. Dividend
5.1 Amount
1AMGN has a Yearly Dividend Yield of 3.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 11.67, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 97.33% of the companies listed in the same industry.
1AMGN's Dividend Yield is a higher than the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
5.2 History
The dividend of 1AMGN is nicely growing with an annual growth rate of 9.41%!
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1AMGN pays out 36.49% of its income as dividend. This is a sustainable payout ratio.
1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.49%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
BIT:1AMGN (10/3/2025, 7:00:00 PM)
253.8
-2.75 (-1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners84.15%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap136.64B
Revenue(TTM)34.92B
Net Income(TTM)6.62B
Analysts72
Price Target274.32 (8.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.22% |
Yearly Dividend7.79
Dividend Growth(5Y)9.41%
DP36.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.69%
Min EPS beat(2)11.64%
Max EPS beat(2)11.73%
EPS beat(4)4
Avg EPS beat(4)8.21%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)4.35%
EPS beat(12)10
Avg EPS beat(12)3.9%
EPS beat(16)14
Avg EPS beat(16)4.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)0.68%
Revenue beat(4)2
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-0.9%
Revenue beat(16)4
Avg Revenue beat(16)-0.92%
PT rev (1m)-2.09%
PT rev (3m)-2.09%
EPS NQ rev (1m)-6.26%
EPS NQ rev (3m)-6.26%
EPS NY rev (1m)1.2%
EPS NY rev (3m)1.2%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 13.32 | ||
| P/S | 4.53 | ||
| P/FCF | 13.88 | ||
| P/OCF | 13.16 | ||
| P/B | 21.28 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.48 |
EPS(TTM)18.85
EY7.43%
EPS(NY)19.05
Fwd EY7.51%
FCF(TTM)18.28
FCFY7.2%
OCF(TTM)19.29
OCFY7.6%
SpS56.07
BVpS11.93
TBVpS-57.58
PEG (NY)1.59
PEG (5Y)2.25
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.53% | ||
| ROE | 89.11% | ||
| ROCE | 16.21% | ||
| ROIC | 14.12% | ||
| ROICexc | 16.03% | ||
| ROICexgc | 59.12% | ||
| OM | 31.3% | ||
| PM (TTM) | 18.96% | ||
| GM | 69.71% | ||
| FCFM | 32.61% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score8
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.24 | ||
| Debt/FCF | 4.94 | ||
| Debt/EBITDA | 3.25 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.72% | ||
| Profit Quality | 172.01% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | N/A |
F-Score8
WACC9.43%
ROIC/WACC1.5
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)17.26%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%21.13%
EPS Next Y8.45%
EPS Next 2Y5.44%
EPS Next 3Y4.87%
EPS Next 5Y4.13%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%9.43%
Revenue Next Year7.54%
Revenue Next 2Y4.58%
Revenue Next 3Y3.91%
Revenue Next 5Y3.12%
EBIT growth 1Y75.18%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year39.98%
EBIT Next 3Y10.33%
EBIT Next 5Y5.65%
FCF growth 1Y17.55%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y11.23%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 13.46 and the Price/Book (PB) ratio is 21.28.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.